PL2337568T3 - Sposoby i środki do inżynierii tkanek miękkich - Google Patents

Sposoby i środki do inżynierii tkanek miękkich

Info

Publication number
PL2337568T3
PL2337568T3 PL09811160T PL09811160T PL2337568T3 PL 2337568 T3 PL2337568 T3 PL 2337568T3 PL 09811160 T PL09811160 T PL 09811160T PL 09811160 T PL09811160 T PL 09811160T PL 2337568 T3 PL2337568 T3 PL 2337568T3
Authority
PL
Poland
Prior art keywords
methods
soft tissue
tissue engineering
engineering
soft
Prior art date
Application number
PL09811160T
Other languages
English (en)
Inventor
Timo Ylikomi
Jertta-Riina Sarkanen
Original Assignee
Everfill Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everfill Oy filed Critical Everfill Oy
Publication of PL2337568T3 publication Critical patent/PL2337568T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • A61K38/1866Vascular endothelial growth factor [VEGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/30Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PL09811160T 2008-09-08 2009-09-07 Sposoby i środki do inżynierii tkanek miękkich PL2337568T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9519808P 2008-09-08 2008-09-08
FI20085839A FI20085839A0 (fi) 2008-09-08 2008-09-08 Menetelmiä ja välineitä pehmytkudosteknologiaan
PCT/FI2009/050715 WO2010026299A1 (en) 2008-09-08 2009-09-07 Methods and means for soft tissue engineering
EP09811160.2A EP2337568B1 (en) 2008-09-08 2009-09-07 Methods and means for soft tissue engineering

Publications (1)

Publication Number Publication Date
PL2337568T3 true PL2337568T3 (pl) 2020-08-10

Family

ID=39852230

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09811160T PL2337568T3 (pl) 2008-09-08 2009-09-07 Sposoby i środki do inżynierii tkanek miękkich

Country Status (12)

Country Link
US (1) US9056084B2 (pl)
EP (1) EP2337568B1 (pl)
JP (1) JP2012502012A (pl)
CN (1) CN102143755A (pl)
BR (1) BRPI0918851B1 (pl)
DK (1) DK2337568T3 (pl)
ES (1) ES2790300T3 (pl)
FI (1) FI20085839A0 (pl)
LT (1) LT2337568T (pl)
PL (1) PL2337568T3 (pl)
PT (1) PT2337568T (pl)
WO (1) WO2010026299A1 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5722217B2 (ja) 2008-09-02 2015-05-20 アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CA2789368C (en) 2010-03-04 2017-10-17 Ajinomoto Co., Inc. Coffee whitener, process for producing same, and process for producing beverage
WO2011109834A2 (en) * 2010-03-05 2011-09-09 President And Fellows Of Harvard College Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
HUE030138T2 (en) 2010-03-22 2017-04-28 Allergan Inc Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
GB201007159D0 (en) * 2010-04-29 2010-06-09 Nhs Blood & Transplant Method for evaluating anglogenic potential
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8926963B2 (en) 2010-08-19 2015-01-06 Allergan, Inc. Compositions and soft tissue replacement methods
US8894992B2 (en) 2010-08-19 2014-11-25 Allergan, Inc. Compositions and soft tissue replacement methods
US8900571B2 (en) 2010-08-19 2014-12-02 Allergan, Inc. Compositions and soft tissue replacement methods
WO2012112757A2 (en) * 2011-02-17 2012-08-23 Allergan, Inc. Compositions and improved soft tissue replacement methods
AU2012262047A1 (en) 2011-06-03 2014-01-16 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
EP2726056A4 (en) * 2011-06-28 2015-01-14 Veris Medical Inc SYSTEM AND METHOD FOR COLLAGEN INSULATION
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
WO2013106715A1 (en) * 2012-01-13 2013-07-18 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
AU2013202570A1 (en) * 2012-03-23 2013-10-10 Neopec Pty Ltd Tissue scaffold
EP2687224A1 (en) * 2012-07-19 2014-01-22 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH Medicament for wound treatment
WO2014164815A2 (en) 2013-03-12 2014-10-09 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
EP3016516A4 (en) * 2013-07-01 2017-03-22 Amit Prakash Govil Soft tissue implant
EP3027235A1 (en) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US9248384B2 (en) 2013-10-02 2016-02-02 Allergan, Inc. Fat processing system
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
EP3653232A1 (en) 2015-02-13 2020-05-20 Allergan Industrie, SAS Implants for sculpting, augmenting or correcting facial features such as the chin
BR112017019272A2 (pt) 2015-03-10 2018-05-02 Allergan Pharmaceuticals Holdings Ireland Unlimited Company injetor de múltiplas agulhas
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US10596321B2 (en) 2016-04-08 2020-03-24 Allergan, Inc. Aspiration and injection device
DK3335696T3 (da) * 2016-12-15 2020-03-16 Upm Kymmene Corp Fremgangsmåde til tørring af cellefrit vævsekstrakt i en hydrogel omfattende nanofibrillær cellulose og en tørret hydrogel omfattende nanofibrillær cellulose og cellefrit vævsekstrakt
IT201700102994A1 (it) * 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
CN110496241A (zh) * 2018-05-16 2019-11-26 上海交通大学医学院附属第九人民医院 取自脂肪组织的生物材料及其制备方法和用途
CN112675153B (zh) * 2019-10-17 2024-12-27 上海萨丽斐生物科技有限公司 无细胞脂肪组织提取物促进毛发生长、固发的用途
EP4552690A3 (en) * 2019-11-15 2025-07-30 Secretome Therapeutics, Inc. Immortalized cardiac stem cells for cardiac repair
CN113398331A (zh) * 2021-05-25 2021-09-17 郑州市和沐生物科技有限公司 无细胞脂肪提取物及其制备方法、分析方法
CN115044541B (zh) * 2022-05-24 2023-08-15 南京农业大学 高分化效率永生猪脂肪前体细胞系及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411621A (pt) * 2003-06-18 2006-08-08 Macropore Biosurgery Inc métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga
WO2005121316A1 (en) * 2004-06-11 2005-12-22 Bernard O'brien Institute Of Microsurgery Tissue material and muscle derived matrix
AU2005282384B2 (en) * 2004-09-08 2011-09-01 Myocardial Therapeutics, Inc. Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
EP2076589B1 (en) * 2006-10-02 2017-02-22 Orthocell Limited A method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair
BRPI0908087A2 (pt) * 2008-02-11 2015-08-25 Univ Johns Hopkins Composições e métodos para implante de tecido adipose e produtos de tecido adiposo

Also Published As

Publication number Publication date
EP2337568A4 (en) 2014-02-19
WO2010026299A1 (en) 2010-03-11
ES2790300T3 (es) 2020-10-27
PT2337568T (pt) 2020-05-15
EP2337568B1 (en) 2020-02-19
US9056084B2 (en) 2015-06-16
FI20085839A0 (fi) 2008-09-08
BRPI0918851A2 (pt) 2015-12-08
LT2337568T (lt) 2020-05-25
DK2337568T3 (da) 2020-05-11
CN102143755A (zh) 2011-08-03
JP2012502012A (ja) 2012-01-26
BRPI0918851B1 (pt) 2019-06-25
US20110151005A1 (en) 2011-06-23
EP2337568A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
LT2337568T (lt) Minkštųjų audinių inžinierijos būdai ir priemonės
IL217340A0 (en) Devices and methods for tissue engineering
IL218663A0 (en) Devices and methods for tissue engineering
EP2211729A4 (en) DEVICES AND METHOD FOR FIXING TISSUE
EP2515787A4 (en) SURGICAL GUIDANCE AND METHOD THEREFOR
SG174985A1 (en) Surgical device and method
GB0803725D0 (en) Surgical apparatus and procedure
IL199797A0 (en) Methods and devices for heart tissue repair
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
GB0802402D0 (en) Medical device and method
ZA201000658B (en) Surgical kits and methods
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2280680A4 (en) METHODS AND DEVICES FOR DISSOLVING TISSUE
EP2222314A4 (en) METHOD AND MEANS FOR OBTAINING BRONCHORELAXATION
GB0903299D0 (en) Composition and methods
GB0802277D0 (en) Medical device and method
LT2442729T (lt) Audinių atstatymo būdas ir rinkinys
TWI370107B (en) Novel methods for making and using halosilylgermanes
IL217734A0 (en) Methods and devices for tissue ablation
GB0823333D0 (en) Apparatus and methods
EP2427129A4 (en) DEVICES AND METHODS FOR MODIFYING FABRICS
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
GB0823408D0 (en) Apparatus and methods
GB0909380D0 (en) Method and use
EP2162084A4 (en) METHOD AND DEVICE FOR TREATMENT OF TISSUE